The Role of the Cerebellum in Schizophrenia: an Update of Clinical, Cognitive, and Functional Evidences

por Picard, Hernàn, Amado, Isabelle, Mouchet-Mages, Sabine, Olié, Jean-Pierre, Krebs, Marie-Odile
Publicado 2008

A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine preven...

por Ashina, Messoud, Doležil, David, Bonner, Jo H, Zhou, Lifen, Klatt, Jan, Picard, Hernan, Mikol, Daniel D
Publicado 2020

Efficacy and safety of erenumab in women with a history of menstrual migraine

por Pavlovic, Jelena M., Paemeleire, Koen, Göbel, Hartmut, Bonner, Jo, Rapoport, Alan, Kagan, Risa, Zhang, Feng, Picard, Hernan, Mikol, Daniel D.
Publicado 2020

Apremilast Long-Term Safety Up to 5 Years from 15 Pooled Randomized, Placebo-Controlled Studies of Psoriasis, Psoriatic Arthritis, and Behçet’s Syndrome

por Mease, Philip J., Hatemi, Gülen, Paris, Maria, Cheng, Sue, Maes, Peter, Zhang, Wendy, Shi, Rebecca, Flower, Andrea, Picard, Hernan, Stein Gold, Linda
Publicado 2023

The Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving ≥50%, ≥75%, and 100% Response

por Broessner, Gregor, Reuter, Uwe, Bonner, Jo H., Dodick, David W., Hallström, Yngve, Picard, Hernan, Zhang, Feng, Lenz, Robert A., Klatt, Jan, Mikol, Daniel D.
Publicado 2020

Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials

por Tepper, Stewart J, Ashina, Messoud, Reuter, Uwe, Hallström, Yngve, Broessner, Gregor, Bonner, Jo H, Picard, Hernan, Cheng, Sunfa, Chou, Denise E, Zhang, Feng, Klatt, Jan, Mikol, Daniel D
Publicado 2021

One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE study

por Goadsby, Peter J., Reuter, Uwe, Hallström, Yngve, Broessner, Gregor, Bonner, Jo H., Zhang, Feng, Wright, Ian K., Chou, Denise E., Klatt, Jan, Picard, Hernan, Lenz, Robert A., Mikol, Daniel D.
Publicado 2020

Early onset of efficacy with erenumab in patients with episodic and chronic migraine

por Schwedt, Todd, Reuter, Uwe, Tepper, Stewart, Ashina, Messoud, Kudrow, David, Broessner, Gregor, Boudreau, Guy P., McAllister, Peter, Vu, Thuy, Zhang, Feng, Cheng, Sunfa, Picard, Hernan, Wen, Shihua, Kahn, Joseph, Klatt, Jan, Mikol, Daniel
Publicado 2018

Vascular safety of erenumab for migraine prevention

por Kudrow, David, Pascual, Julio, Winner, Paul K., Dodick, David W., Tepper, Stewart J., Reuter, Uwe, Hong, Frank, Klatt, Jan, Zhang, Feng, Cheng, Sunfa, Picard, Hernan, Eisele, Osa, Wang, Julie, Latham, Jonathan N., Mikol, Daniel D.
Publicado 2020